NMDA receptor binding in focal epilepsies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 10, 2015, Pages 1150-1157

  McGinnity, C J ^a,b,c   Koepp, M J ^d,e   Hammers, A ^a,b,c,d,e,f   Riano Barros D A ^a,b   Pressler, R M ^g   Luthra, S ^h   Jones, P A ^h   Trigg, W ^h   Micallef, C ⁱ   Symms, M R ^d,e   Brooks, D J ^a,j   Duncan, J S ^d,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e EPILEPSY SOCIETY   (United Kingdom)

^f CERMEP IMAGERIE DU VIVANT   (France)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h GE HEALTHCARE   (United Kingdom)

ⁱ NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^j AARHUS UNIVERSITY   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; FEXOFENADINE; FLUOXETINE; GE 179 F 18; HARKOSERIDE; LAMOTRIGINE; LOFEPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXCARBAZEPINE; PHENYTOIN; RUFINAMIDE; SERTRALINE; TOPIRAMATE; TRACER; UNCLASSIFIED DRUG; VALPROIC ACID; ZONISAMIDE; ANTIDEPRESSANT AGENT; CARBAZOLE DERIVATIVE; GE-180; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; VOLUME OF DISTRIBUTION; YOUNG ADULT; BRAIN MAPPING; DRUG EFFECTS; DRUG INTERACTION; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; METABOLISM; SCINTISCANNING;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CARBAZOLES; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 84942263847     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309897     Document Type: Article

References (67)

1. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365-402.
2. Wollmuth LP, Sobolevsky AI. Structure and gating of the glutamate receptor ion channel. Trends Neurosci 2004;27:321-8.
3. Leker RR, Shohami E, Leker RR, et al. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 2002;39:55-73.
4. Sattler R, Xiang ZG, Lu WY, et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999;284:1845-8.
5. Waxman EA, Lynch DR, Waxman EA, et al. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005;11:37-49.
6. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012;62:63-77.
7. Musazzi L, Treccani G, Mallei A, et al. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry 2013;73:1180-8.
8. Lau CG, Zukin RS, Lau CG, et al. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007;8:413-26.
9. Turski L, Niemann W, Stephens DN. Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids. Neuroscience 1990;39:799-807.
10. Chiamulera C, Costa S, Reggiani A. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology (Berl) 1990;102:551-2.
11. Scerrati M, Onofrj M, Pacifici L, et al. Electrocerebral and behavioural analysis of systemic kainic acid-induced epilepsy in the rat. Drugs Exp Clin Res 1986;12:671-80.
12. De Deyn PP, D'Hooge R, Marescau B, et al. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res 1992;12:87-110.
13. Brandt C, Potschka H, Loscher W, et al. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 2003;118:727-40.
14. Anderson WW, Lewis DV, Swartzwelder HS, et al. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res 1986;398:215-19.
15. Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987;57:869-88.
16. Baldino F Jr, Wolfson B, Heinemann U, et al. An N-methyl-D-aspartate (NMDA) receptor antagonist reduces bicuculline-induced depolarization shifts in neocortical explant cultures. Neurosci Lett 1986;70:101-5.
17. Uchida K. Excitatory amino acid receptors appear to mediate paroxysmal depolarizing shifts in rat neocortical neurons in vitro. Brain Res 1992;577:151-4.
18. Croucher MJ, Bradford HF, Sunter DC, et al. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol 1988;152:29-38.
19. Croucher MJ, Cotterell KL, Bradford HF. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochem Res 1992;17:409-13.
20. Vezzani A, Wu HQ, Moneta E, et al. Role of the N-methyl-D-aspartate-type receptors in the development and maintenance of hippocampal kindling in rats. Neurosci Lett 1988;87:63-8.
21. Savage DD, Werling LL, Nadler JV, et al. Selective increase in L-[3H]glutamate binding to a quisqualate-sensitive site on hippocampal synaptic membranes after angular bundle kindling. Eur J Pharmacol 1982;85:255-6.
22. Yeh GC, Bonhaus DW, Nadler JV, et al. N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspartate receptor-channel complex. Proc Natl Acad Sci USA 1989;86:8157-60.
23. Geddes JW, Cahan LD, Cooper SM, et al. Altered distribution of excitatory amino acid receptors in temporal lobe epilepsy. Exp Neurol 1990;108:214-20.
24. Hosford DA, Crain BJ, Cao Z, et al. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J Neurosci 1991;11:428-34.
25. Louvel J, Pumain R, Avoli M, et al. GABAA inhibition controls the calcium flows during NMDA-dependent epileptiform activity in human epileptogenic neocortex. Epilepsy Res Suppl 1996;12:293-300.
26. Cohen I, Navarro V, Clemenceau S, et al. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002;298:1418-21.
27. Huberfeld G, Menendez de la Prida L, Pallud J, et al. Glutamatergic pre-ictal discharges emerge at the transition to seizure in human epilepsy. Nat Neurosci 2011;14:627-34.
28. Franck JE, Pokorny J, Kunkel DD, et al. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia 1995;36:543-58.
29. Isokawa M, Fried I. Extracellular slow negative transient in the dentate gyrus of human epileptic hippocampus in vitro. Neuroscience 1996;72:31-7.
30. Kim YI, Peacock WJ, Dudek FE. Properties and synaptic mechanisms of bicuculline-induced epileptiform bursts in neocortical slices from children with intractable epilepsy. J Neurophysiol 1993;70:1759-66.
31. Wilson CL, Maidment NT, Shomer MH, et al. Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res 1996;26:245-54.
32. Carlson H, Ronne-Engstrom E, Ungerstedt U, et al. Seizure related elevations of extracellular amino acids in human focal epilepsy. Neurosci Lett 1992;140:30-2.
33. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993;341:1607-10.
34. Thomas PM, Phillips JP, O'Connor WT. Hippocampal microdialysis during spontaneous intraoperative epileptiform activity. Acta Neurochir (Wien) 2004;146:143-51.
35. Hamberger A, Nystrom B, Larsson S, et al. Amino acids in the neuronal microenvironment of focal human epileptic lesions. Epilepsy Res 1991;9:32-43.
36. Ronne-Engstrom E, Hillered L, Flink R, et al. Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 1992;12:873-6.
37. Thomas PM, Phillips JP, Delanty N, et al. Elevated extracellular levels of glutamate, aspartate and gamma-aminobutyric acid within the intraoperative, spontaneously epileptiform human hippocampus. Epilepsy Res 2003;54:73-9.
38. McGinnity CJ, Hammers A, Riano Barros DA, et al. Initial evaluation of 18F-GE-179, a putative PET tracer for activated N-methyl D-aspartate receptors. J Nucl Med 2014;55:423-30.
39. Waterhouse RN, Waterhouse RN. Imaging the PCP site of the NMDA ion channel. Nucl Med Biol 2003;30:869-78.
40. Centeno M, Feldmann M, Harrison NA, et al. Epilepsy causing pupillary hippus: an unusual semiology. Epilepsia 2011;52:e93-6.
41. Devous MD, Thisted RA, Morgan GF, et al. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 1998;39:285-93.
42. Kahane P, Merlet I, Gregoire MC, et al. An H(2) (15)O-PET study of cerebral blood flow changes during focal epileptic discharges induced by intracerebral electrical stimulation. Brain 1999;122(Pt 10):1851-65.
43. Lester RA, Jahr CE. NMDA channel behavior depends on agonist affinity. J Neurosci 1992;12:635-43.
44. Korinek M, Sedlacek M, Cais O, et al. Temperature dependence of N-methyl-Daspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents. Neuroscience 2010;165:736-48.
45. Nong Y, Huang YQ, Ju W, et al. Glycine binding primes NMDA receptor internalization. Nature 2003;422:302-7.
46. Roche KW, Standley S, McCallum J, et al. Molecular determinants of NMDA receptor internalization. Nat Neurosci 2001;4:794-802.
47. Han L, Campanucci VA, Cooke J, et al. Identification of a single amino acid in GluN1 that is critical for glycine-primed internalization of NMDA receptors. Mol Brain 2013;6:36.
48. Vyklický L, Benveniste M, Mayer ML. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones. J Physiol 1990;428:313-31.
49. Lin F, Stevens CF. Both open and closed NMDA receptor channels desensitize. J Neurosci 1994;14:2153-60.
50. Nahum-Levy R, Lipinski D, Shavit S, et al. Desensitization of NMDA receptor channels is modulated by glutamate agonists. Biophys J 2001;80:2152-66.
51. Kumlien E. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 1999;40:30-7.
52. Boyer PA, Skolnick P, Fossom LH. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain: a quantitative in situ hybridization study. J Mol Neurosci 1998;10:219-33.
53. Tokarski K, Bobula B, Wabno J, et al. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience 2008;153:789-95.
54. Paul IA, Nowak G, Layer RT, et al. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 1994;269:95-102.
55. Skolnick P, Layer RT, Popik P, et al. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996;29:23-6.
56. Nowak G, Trullas R, Layer RT, et al. Adaptive changes in the N-methyl-Daspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 1993;265:1380-6.
57. Nowak G, Legutko B, Skolnick P, et al. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. Eur J Pharmacol 1998;342:367-70.
58. Ryan B, Musazzi L, Mallei A, et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol 2009;12:553-9.
59. Pittaluga A, Raiteri L, Longordo F, et al. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology 2007;53:27-36.
60. Musazzi L, Milanese M, Farisello P, et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS ONE 2010;5:e8566.
61. Bonanno G, Giambelli R, Raiteri L, et al. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 2005;25:3270-9.
62. Kuo CC, Lin BJ, Chang HR, et al. Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels. Mol Pharmacol 2004;65:370-80.
63. Chang HR, Kuo CC. Characterization of the gating conformational changes in the felbamate binding site in NMDA channels. Biophys J 2007;93:456-66.
64. Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013;54:1498-503.
65. Rosati A, L'Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology 2012;79:2355-8.
66. Synowiec AS, Singh DS, Yenugadhati V, et al. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013;105:183-8.
67. MacDonald JF, Bartlett MC, Mody I, et al. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol 1991;432:483-508.